Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mafalda Seabra

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|July 3, 2020
Optic neuropathy: A 15-year retrospective observational studyJosé Miguel Alves, Mafalda Seabra, Luís Braz, et al.
Cureus|January 9, 2020
Vanishing Pseudotumoral White Matter Lesions Presenting as Aphasia and Altered Mental Status in a 71-Year-Old MaleDaniela Ferro, Mafalda Seabra, Isabel Taveira, et al.
Practical Neurology|April 19, 2019
Brody disease: when myotonia is not myotoniaLuís Braz, Ricardo Soares-Dos-Reis, Mafalda Seabra, et al.
Epilepsy & Behavior : E&B|October 7, 2023
Epilepsy hospitalizations and mental disorders: A Portuguese population-based observational retrospective study (2008-2015)Marta Silva, Manuel Gonçalves-Pinho, Ana Rita Ferreira, et al.
Acta Neurologica Belgica|January 9, 2020
Systemic inflammation status at admission affects the outcome of intracerebral hemorrhage by increasing perihematomal edema but not the hematoma growthSérgio Fonseca, Francisca Costa, Mafalda Seabra, et al.
Journal of Clinical Neurology (Seoul, Korea)|May 1, 2025
Multiple Sclerosis After the Age of 50 Years: A Comparative Analysis of Late Onset and Adult OnsetRicardo Soares-Dos-Reis, Pedro Silva, Francisca Ferreira, et al.
Multiple Sclerosis and Related Disorders|November 20, 2025
Exploring the wearing-off phenomenon among anti-CD20 therapies in multiple sclerosisAndré Aires Fernandes, Carolina Correia, Beatriz Barreto, et al.
Multiple Sclerosis and Related Disorders|July 10, 2021
Natural history of relapsing remitting multiple sclerosis in a long-lasting cohort from a tertiary MS centre in PortugalMaria José Sá, Lucinda Sequeira, Daniela Ferro, et al.
Acta Medica Portuguesa|July 15, 2026
[Guidelines for the Management of Secondary Hypogammaglobulinemia in Multiple Sclerosis Patients on Anti-CD20 Monoclonal Antibody Therapy]André Aires Fernandes, Ana Lídia Neves, Daniela Ferro, et al.
Frontiers in Neurology|January 21, 2025
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile studyAndré Aires Fernandes, Ana Lídia Neves, Daniela Ferro, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|July 3, 2020
Optic neuropathy: A 15-year retrospective observational studyJosé Miguel Alves, Mafalda Seabra, Luís Braz, et al.
Cureus|January 9, 2020
Vanishing Pseudotumoral White Matter Lesions Presenting as Aphasia and Altered Mental Status in a 71-Year-Old MaleDaniela Ferro, Mafalda Seabra, Isabel Taveira, et al.
Practical Neurology|April 19, 2019
Brody disease: when myotonia is not myotoniaLuís Braz, Ricardo Soares-Dos-Reis, Mafalda Seabra, et al.
Epilepsy & Behavior : E&B|October 7, 2023
Epilepsy hospitalizations and mental disorders: A Portuguese population-based observational retrospective study (2008-2015)Marta Silva, Manuel Gonçalves-Pinho, Ana Rita Ferreira, et al.
Acta Neurologica Belgica|January 9, 2020
Systemic inflammation status at admission affects the outcome of intracerebral hemorrhage by increasing perihematomal edema but not the hematoma growthSérgio Fonseca, Francisca Costa, Mafalda Seabra, et al.
Journal of Clinical Neurology (Seoul, Korea)|May 1, 2025
Multiple Sclerosis After the Age of 50 Years: A Comparative Analysis of Late Onset and Adult OnsetRicardo Soares-Dos-Reis, Pedro Silva, Francisca Ferreira, et al.
Multiple Sclerosis and Related Disorders|November 20, 2025
Exploring the wearing-off phenomenon among anti-CD20 therapies in multiple sclerosisAndré Aires Fernandes, Carolina Correia, Beatriz Barreto, et al.
Multiple Sclerosis and Related Disorders|July 10, 2021
Natural history of relapsing remitting multiple sclerosis in a long-lasting cohort from a tertiary MS centre in PortugalMaria José Sá, Lucinda Sequeira, Daniela Ferro, et al.
Acta Medica Portuguesa|July 15, 2026
[Guidelines for the Management of Secondary Hypogammaglobulinemia in Multiple Sclerosis Patients on Anti-CD20 Monoclonal Antibody Therapy]André Aires Fernandes, Ana Lídia Neves, Daniela Ferro, et al.
Frontiers in Neurology|January 21, 2025
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile studyAndré Aires Fernandes, Ana Lídia Neves, Daniela Ferro, et al.
Pageof 2